Suchergebnisse
Omeros Q2 Earnings Call Highlights
Key Points
- Interested in Omeros Corporation? Here are five stocks we like better.
- YARTEMLEA sales surged in its first full quarter, reaching $28.5 million in net sales, up 188% sequentially
Nano Nuclear Energy Q3 Earnings Call Highlights
Key Points
- Interested in Nano Nuclear Energy Inc.? Here are five stocks we like better.
- Kronos licensing advanced: The NRC accepted Nano Nuclear’s construction permit application for review
MaxCyte Q2 Earnings Call Highlights
Key Points
- Interested in MaxCyte, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 15% year over year to $7.3 million, though results exceeded management’s expectations
Marchex Q2 Earnings Call Highlights
Key Points
- Interested in Marchex, Inc.? Here are five stocks we like better.
- Marchex reported Q2 revenue of $11 million, up from $10.6 million in Q1, and forecast Q3 revenue of $16 million to
Lulu's Fashion Lounge Q2 Earnings Call Highlights
Key Points
- Interested in Lulu's Fashion Lounge Holdings, Inc.? Here are five stocks we like better.
- Revenue fell 17% year over year to $67.8 million, pressured by lower order volume, elevated
Lumexa Imaging Q2 Earnings Call Highlights
Key Points
- Interested in Lumexa Imaging Holdings, Inc.? Here are five stocks we like better.
- Lumexa returned to profitability in Q2: Revenue rose 5.1% year over year to $264.2 million, net
Liftoff Mobile Q2 Earnings Call Highlights
Key Points
- Interested in Liftoff Mobile, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue increased 35% year over year to $220 million, while adjusted EBITDA
STAAR Surgical Q2 Earnings Call Highlights
Key Points
- Interested in STAAR Surgical Company? Here are five stocks we like better.
- STAAR Surgical reported a strong second quarter: Net sales more than doubled to $93.5 million, while the
Spero Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Spero Therapeutics, Inc.? Here are five stocks we like better.
- Utebzi was approved by the FDA for certain complicated urinary tract infections, with GSK expected to
SKYX Platforms Q2 Earnings Call Highlights
Key Points
- Interested in SKYX Platforms Corp.? Here are five stocks we like better.
- Record Q2 revenue reached $25.3 million, up 14% sequentially and 10% year over year, marking SKYX’s 10th
Sera Prognostics Q2 Earnings Call Highlights
Key Points
- Interested in Sera Prognostics, Inc.? Here are five stocks we like better.
- Revenue remained modest at $30,000 in Q2, up from $17,000 a year earlier, while the net loss widened to $9.1
comScore Q2 Earnings Call Highlights
Key Points
- Interested in comScore, Inc.? Here are five stocks we like better.
- Q2 performance weakened sharply: Revenue fell 11.3% year over year to $79.2 million, while adjusted EBITDA dropped
Red Robin Gourmet Burgers Q2 Earnings Call Highlights
Key Points
- Interested in Red Robin Gourmet Burgers, Inc.? Here are five stocks we like better.
- Comparable sales rose 1.3% in the second quarter, with traffic effectively flat and
RenovoRx Q2 Earnings Call Highlights
Key Points
- Interested in RenovoRx, Inc.? Here are five stocks we like better.
- Record commercial growth: Second-quarter revenue rose 115% year over year to $909,000, supported by increased
Perma-Fix Environmental Services Q2 Earnings Call Highlights
Key Points
- Interested in Perma-Fix Environmental Services, Inc.? Here are five stocks we like better.
- Second-quarter results missed expectations: Revenue fell to $12.9 million from $14.6 million